Endothelial cell HIF-1α and HIF-2α differentially regulate metastatic success

Cancer Cell

Volumn 21, Issue 1, 2012, Pages 52-65

  Branco Price, Cristina ^a   Zhang, Na ^b   Schnelle, Moritz ^d   Evans, Colin ^a   Katschinski, Dörthe M ^d   Liao, Debbie ^b   Ellies, Lesley ^c   Johnson, RandallS ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CELL ACTIVATION; ENDOTHELIUM CELL; FEEDBACK SYSTEM; GENE DELETION; GENE EXPRESSION; HOMEOSTASIS; IMMUNOPRECIPITATION; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSGENICS; TUMOR CELL;

EID: 84862909156     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2011.11.017     Document Type: Article

References (70)

1. Ambs S., Merriam W.G., Bennett W.P., Felley-Bosco E., Ogunfusika M.O., Oser S.M., Klein S., Shields P.G., Billiar T.R., Harris C.C. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 1998, 58:334-341.
2. Amirkhosravi A., Mousa S.A., Amaya M., Meyer T., Davila M., Robson T., Francis J.L. Assessment of anti-metastatic effects of anticoagulant and antiplatelet agents using animal models of experimental lung metastasis. Methods Mol. Biol. 2010, 663:241-259.
3. Berchner-Pfannschmidt U., Yamac H., Trinidad B., Fandrey J. Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase 2. J.Biol. Chem. 2007, 282:1788-1796.
4. Bertout J.A., Majmundar A.J., Gordan J.D., Lam J.C., Ditsworth D., Keith B., Brown E.J., Nathanson K.L., Simon M.C. HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses. Proc. Natl. Acad. Sci. USA 2009, 106:14391-14396.
5. Brizel D.M., Scully S.P., Harrelson J.M., Layfield L.J., Bean J.M., Prosnitz L.R., Dewhirst M.W. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 1996, 56:941-943.
6. Chambers A.F., Groom A.C., MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2002, 2:563-572.
7. Chen J., Imanaka N., Chen J., Griffin J.D. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br. J. Cancer 2010, 102:351-360.
8. Claffey K.P., Brown L.F., del Aguila L.F., Tognazzi K., Yeo K.T., Manseau E.J., Dvorak H.F. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth,angiogenesis, and experimental metastasis. Cancer Res. 1996, 56:172-181.
9. Cliffton E.E., Grossi C.E. The rationale of anticoagulants in the treatment of cancer. J.Med. 1974, 5:107-113.
10. Constien R., Forde A., Liliensiek B., Gröne H.J., Nawroth P., Hämmerling G., Arnold B. Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis 2001, 30:36-44.
11. Coulon C., Georgiadou M., Roncal C., De Bock K., Langenberg T., Carmeliet P. From vessel sprouting to normalization: role of the prolyl hydroxylase domain protein/hypoxia-inducible factor oxygen-sensing machinery. Arterioscler. Thromb. Vasc. Biol. 2010, 30:2331-2336.
12. Davie S.A., Maglione J.E., Manner C.K., Young D., Cardiff R.D., MacLeod C.L., Ellies L.G. Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice. Transgenic Res. 2007, 16:193-201.
13. De Jaeger K., Merlo F.M., Kavanagh M.C., Fyles A.W., Hedley D., Hill R.P. Heterogeneity of tumor oxygenation: relationship to tumor necrosis, tumor size, and metastasis. Int. J. Radiat. Oncol. Biol. Phys. 1998, 42:717-721.
14. Doedens A.L., Stockmann C., Rubinstein M.P., Liao D., Zhang N., DeNardo D.G., Coussens L.M., Karin M., Goldrath A.W., Johnson R.S. Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res. 2010, 70:7465-7475.
15. Dong Q.G., Bernasconi S., Lostaglio S., De Calmanovici R.W., Martin-Padura I., Breviario F., Garlanda C., Ramponi S., Mantovani A., Vecchi A. A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. Arterioscler. Thromb. Vasc. Biol. 1997, 17:1599-1604.
16. Erler J.T., Giaccia A.J. Lysyl oxidase mediates hypoxic control of metastasis. Cancer Res. 2006, 66:10238-10241.
17. Fukumura D., Gohongi T., Kadambi A., Izumi Y., Ang J., Yun C.O., Buerk D.G., Huang P.L., Jain R.K. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc. Natl. Acad. Sci. USA 2001, 98:2604-2609.
18. Fukumura D., Kashiwagi S., Jain R.K. The role of nitric oxide in tumour progression. Nat. Rev. Cancer 2006, 6:521-534.
19. Gerber H.P., Hillan K.J., Ryan A.M., Kowalski J., Keller G.A., Rangell L., Wright B.D., Radtke F., Aguet M., Ferrara N. VEGF is required for growth and survival in neonatal mice. Development 1999, 126:1149-1159.
20. Gordan J.D., Bertout J.A., Hu C.J., Diehl J.A., Simon M.C. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 2007, 11:335-347.
21. Gruber M., Hu C.J., Johnson R.S., Brown E.J., Keith B., Simon M.C. Acute postnatal ablation of Hif-2alpha results in anemia. Proc. Natl. Acad. Sci. USA 2007, 104:2301-2306.
22. Gunnett C.A., Lund D.D., McDowell A.K., Faraci F.M., Heistad D.D. Mechanisms of inducible nitric oxide synthase-mediated vascular dysfunction. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1617-1622.
23. Gupta G.P., Massagué J. Cancer metastasis: building a framework. Cell 2006, 127:679-695.
24. Haase V.H. Hypoxia-inducible factors in the kidney. Am. J. Physiol. Renal Physiol. 2006, 291:F271-F281.
25. Haase V.H. Oxygen regulates epithelial-to-mesenchymal transition: insights into molecular mechanisms and relevance to disease. Kidney Int. 2009, 76:492-499.
26. Holmquist-Mengelbier L., Fredlund E., Löfstedt T., Noguera R., Navarro S., Nilsson H., Pietras A., Vallon-Christersson J., Borg A., Gradin K., et al. Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 2006, 10:413-423.
27. Hosogi H., Ikai I., Hatano E., Taura K., Fujii H., Yamamoto N., Shimahara Y. Complete response by a combination of 5-fluorouracil and interferon-alpha chemotherapy for lung metastasis of hepatocellular carcinoma after hepatic resection with portal and hepatic vein tumor thrombectomy. Hepatol. Res. 2005, 33:320-324.
28. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 1987, 84:9265-9269.
29. Kisanuki Y.Y., Hammer R.E., Miyazaki J., Williams S.C., Richardson J.A., Yanagisawa M. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis invivo. Dev. Biol. 2001, 230:230-242.
30. Kondo K., Klco J., Nakamura E., Lechpammer M., Kaelin W.G. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 2002, 1:237-246.
31. Liao D., Corle C., Seagroves T.N., Johnson R.S. Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Cancer Res. 2007, 67:563-572.
32. Lin E.Y., Jones J.G., Li P., Zhu L., Whitney K.D., Muller W.J., Pollard J.W. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am. J. Pathol. 2003, 163:2113-2126.
33. Liu S., Guo W., Shi J., Li N., Yu X., Xue J., Fu X., Chu K., Lu C., Zhao J., et al. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J.Hepatol. 2011, [Epub ahead of print].
34. Lu X., Yan C.H., Yuan M., Wei Y., Hu G., Kang Y. Invivo dynamics and distinct functions of hypoxia in primary tumor growth and organotropic metastasis of breast cancer. Cancer Res. 2010, 70:3905-3914.
35. Mark K.S., Burroughs A.R., Brown R.C., Huber J.D., Davis T.P. Nitric oxide mediates hypoxia-induced changes in paracellular permeability of cerebral microvasculature. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H174-H180.
36. Mazzone M., Dettori D., Leite de Oliveira R., Loges S., Schmidt T., Jonckx B., Tian Y.M., Lanahan A.A., Pollard P., Ruiz de Almodovar C., et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 2009, 136:839-851.
37. Melillo G., Musso T., Sica A., Taylor L.S., Cox G.W., Varesio L. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J.Exp. Med. 1995, 182:1683-1693.
38. Melillo G., Taylor L.S., Brooks A., Musso T., Cox G.W., Varesio L. Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J.Biol. Chem. 1997, 272:12236-12243.
39. Ohtsu N., Takaoka K., Segawa E., Hashitani S., Noguchi K., Kishimoto H., Urade M. Antitumor effects of inhibitors of nitric oxide synthase or cyclooxygenase-2 on human KB carcinoma cells overexpressing COX-2. Oncol. Rep. 2010, 24:31-36.
40. Olson N., van der Vliet A. Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease. Nitric Oxide 2011, 25:125-137.
41. Ortiz-Masiá D., Hernández C., Quintana E., Velázquez M., Cebrián S., Riaño A., Calatayud S., Esplugues J.V., Barrachina M.D. iNOS-derived nitric oxide mediates the increase in TFF2 expression associated with gastric damage: role of HIF-1. FASEB J. 2010, 24:136-145.
42. Ostrowski L.E., Ahsan A., Suthar B.P., Pagast P., Bain D.L., Wong C., Patel A., Schultz R.M. Selective inhibition of proteolytic enzymes in an invivo mouse model for experimental metastasis. Cancer Res. 1986, 46:4121-4128.
43. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526.
44. Palumbo J.S., Talmage K.E., Massari J.V., La Jeunesse C.M., Flick M.J., Kombrinck K.W., Jirousková M., Degen J.L. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 2005, 105:178-185.
45. Roberts A.M., Watson I.R., Evans A.J., Foster D.A., Irwin M.S., Ohh M. Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells. Cancer Res. 2009, 69:9056-9064.
46. Rofstad E.K., Danielsen T. Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis. Br. J. Cancer 1999, 80:1697-1707.
47. Rofstad E.K., Gaustad J.V., Egeland T.A., Mathiesen B., Galappathi K. Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination. Int. J. Cancer 2010, 127:1535-1546.
48. Ryan H.E., Lo J., Johnson R.S. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 1998, 17:3005-3015.
49. Ryan H.E., Poloni M., McNulty W., Elson D., Gassmann M., Arbeit J.M., Johnson R.S. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res. 2000, 60:4010-4015.
50. Saito D., Sawamura M., Umezawa K., Kanai Y., Furihata C., Matsushima T., Sugimura T. Inhibition of experimental blood-borne lung metastasis by protease inhibitors. Cancer Res. 1980, 40:2539-2542.
51. Schneider M., Van Geyte K., Fraisl P., Kiss J., Aragones J., Mazzone M., Mairbaurl H., De Bock K., Jeoung N.H., Mollenhauer M., et al. Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury. Gastroenterology 2010, 138:1143-1154.
52. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845.
53. Skuli N., Simon M.C. HIF-1alpha versus HIF-2alpha in endothelial cells and vascular functions: is there a master in angiogenesis regulation?. CellCycle 2009, 8:3252-3253.
54. Skuli N., Liu L., Runge A., Wang T., Yuan L., Patel S., Iruela-Arispe L., Simon M.C., Keith B. Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis. Blood 2009, 114:469-477.
55. Smith K., Gunaratnam L., Morley M., Franovic A., Mekhail K., Lee S. Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancer. Cancer Res. 2005, 65:5221-5230.
56. Tafani M., Russo A., Di Vito M., Sale P., Pellegrini L., Schito L., Gentileschi S., Bracaglia R., Marandino F., Garaci E., Russo M.A. Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment. Cancer Sci. 2010, 101:1014-1023.
57. Takeda N., O'Dea E.L., Doedens A., Kim J.W., Weidemann A., Stockmann C., Asagiri M., Simon M.C., Hoffmann A., Johnson R.S. Differential activation and antagonistic function of HIF-alpha isoforms in macrophages are essential for NO homeostasis. Genes Dev. 2010, 24:491-501.
58. Tang N., Wang L., Esko J., Giordano F.J., Huang Y., Gerber H.P., Ferrara N., Johnson R.S. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 2004, 6:485-495.
59. Ten V.S., Pinsky D.J. Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction. Curr. Opin. Crit. Care 2002, 8:242-250.
60. Thomsen L.L., Scott J.M., Topley P., Knowles R.G., Keerie A.J., Frend A.J. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth invivo: studies with 1400W, a novel inhibitor. Cancer Res. 1997, 57:3300-3304.
61. Van der Wall H., Palmer A. On the AJR viewbox. Monomelic spread of metastatic disease due to proximal deep venous thrombosis. AJR Am. J. Roentgenol. 2006, 186:1797-1799.
62. Voss M.J., Möller M.F., Powe D.G., Niggemann B., Zänker K.S., Entschladen F. Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism. BMC Cancer 2011, 11:158.
63. Wang B., Xiong Q., Shi Q., Tan D., Le X., Xie K. Genetic disruption of host nitric oxide synthase II gene impairs melanoma-induced angiogenesis and suppresses pleural effusion. Int. J. Cancer 2001, 91:607-611.
64. Weis S., Cui J., Barnes L., Cheresh D. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J.Cell Biol. 2004, 167:223-229.
65. Yamashita T., Ohneda K., Nagano M., Miyoshi C., Kaneko N., Miwa Y., Yamamoto M., Ohneda O., Fujii-Kuriyama Y. Hypoxia-inducibletranscription factor-2alpha in endothelial cells regulates tumor neovascularization through activation of ephrin A1. J.Biol. Chem. 2008, 283:18926-18936.
66. Yang M.H., Wu M.Z., Chiou S.H., Chen P.M., Chang S.Y., Liu C.J., Teng S.C., Wu K.J. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat. Cell Biol. 2008, 10:295-305.
67. Zhang Z., Neiva K.G., Lingen M.W., Ellis L.M., Nör J.E. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. Cell Death Differ. 2010, 17:499-512.
68. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., Buechler P., Isaacs W.B., Semenza G.L., Simons J.W. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999, 59:5830-5835.
69. Zhou J., Dehne N., Brüne B. Nitric oxide causes macrophage migration via the HIF-1-stimulated small GTPases Cdc42 and Rac1. Free Radic. Biol. Med. 2009, 47:741-749.
70. Ziche M., Morbidelli L. Molecular regulation of tumour angiogenesis by nitric oxide. Eur. Cytokine Netw. 2009, 20:164-170.